Evidence map›Paper›PMID 16731947›Full record

ArticleJournal of virology2006

Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus.

Veronika von Messling, Nicholas Svitek, Roberto Cattaneo

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 154 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  6. Meningoencephalitis caused by concurrent infection with canine distemper virus and a uniqueJournal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Veronika von MesslingMayo Clinic College of Medicine, Rochester, MN 55902, USA.
Nicholas Svitek
Roberto Cattaneo
Institut National de la Recherche Scientifique · CAMayo Clinic · US

Funding

Immunosuppression and Innate Immunity Control by MorbillivirusesR01AI063476 · NIAID · MAYO CLINIC ROCHESTER · PI CATTANEO, ROBERTO B. · 2005 to 2014
$3.2M
Measles Virus Entry: Engagement of the Receptors and Infection ProgressionR01CA090636 · NCI · MAYO CLINIC ROCHESTER · PI CATTANEO, ROBERTO B. · 2002 to 2011
$2.4M
NCI NIH HHS CA90636NCI NIH HHS R01 CA090636NIAID NIH HHS AI63476NIAID NIH HHS R01 AI063476
6 · The paper itself

Abstract

Experimental infections of ferrets with canine distemper virus (CDV) recapitulate many hallmarks of measles: rash, high fever, viremia, depression of delayed-type hypersensitivity responses, lowered leukocyte counts, and reduced lymphocyte proliferation activity. To understand how a morbillivirus invades the host and causes immunosuppression, we generated CDV either unable to recognize one of the receptors or incapable of expressing either one or both of the candidate interferon antagonist proteins V and C. Variants of these viruses expressing green fluorescent protein were also generated. Striking similarities between CDV infection of ferrets and human immunodeficiency virus host invasion were documented: first, massive early replication in the gut-associated lymphatic tissue, including intestinal Peyer's patches, followed by extensive infection of lymphatic organs, including thymus and circulating lymphocytes. Moreover, T cells were selectively depleted. Thus, CDV takes advantage of mucosal surfaces for host invasion and lymphocytes for swift dissemination. A CDV unable to recognize the signaling lymphocytic activation molecule (SLAM [CD150]) that is expressed in lymphocytes and other immune cells did not spread. A V-defective CDV multiplied with reduced efficiency in lymphocytes and did not inhibit the interferon and cytokine responses. Protein C affected the severity of rash and digestive symptoms elicited by V-defective CDV, but it was dispensable for the invasion of the lymphatic organs. These findings prove formally that SLAM recognition is necessary for morbillivirus virulence. They also reveal how two viral proteins affect pathogenesis: V sustains the swift lymphocyte-based invasion of mucosal tissue and lymphatic organs, whereas C sustains subsequent infection phases.

Indexed as

AnimalsAntigens, CDCell LineDogsFerretsGlycoproteinsHumansImmunoglobulinsKineticsLymphocytesMorbillivirusMorbillivirus InfectionsMucous MembraneReceptors, Cell SurfaceSignaling Lymphocytic Activation Molecule Family Member 1Viral ProteinsAntigens, CDGlycoproteinsImmunoglobulinsReceptors, Cell SurfaceSignaling Lymphocytic Activation Molecule Family Member 1SLAMF1 protein, humanViral Proteins

Identifiers

PMID16731947
PMCPMC1472607
OpenAlexW2171742026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.